Actavis Buying Spree Includes Alpharma In Race For Generic Top Three

Actavis plans to acquire Alpharma's generic drug business for $810 mil., marking the Reykjavik, Iceland based company's seventh acquisition of the year

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet